CMDFCapital Market Development Fund
CMDFCanadian Medical Discoveries Fund, Inc.
CMDFCombined Miniature Deterrent Forces (science-fiction film Fantastic Voyage)
CMDFChildren's Motility Disorder Foundation
CMDFCombined Main Distribution Frame (Sprint)
CMDFCatalog Master Data File
CMDFContract Monitoring Data File
CMDFCommunity and Media Development Fund (Belarus)
References in periodicals archive ?
Both the original CMDF and resin-infused samples displayed the abrupt fracture behavior typical of brittle materials as shown by their tensile stress-strain profiles (Fig.
The tensile properties of the original CMDF were considerably improved after resin infusion (Table 1), with tensile strength increasing 434 percent and 235 percent for the epoxy-infused CMDF and phenolic-infused CMDF, respectively, and the tensile modulus increasing 138 percent and 97 percent for the epoxy-infused and phenolic-infused samples, respectively.
This resin infusion disproportionately improved the properties of the CMDF core material compared to the surface layers; this resulted in a material with proportionally greater tensile strength than bending strength.
It is conceivable that the use of the CMDF material would significantly reduce the production cost as complex fiber handling and forming procedures can be reduced or eliminated for some applications.
Under the terms of the transaction, CMDF and the other investors have been granted warrants to acquire 500,000 common shares of Spectral at an exercise price of $3.
We are particularly pleased to be working with CMDF and the advisory and management services of MDS Capital Corp.
said Dan Nixon, Vice President, CMDF and Managing Director, Private Equity, MDS Capital Corp.
CMDF continues to hold options to acquire an additional 535,700 common shares of Drug Royalty of which one-half are exercisable at $2.
In other developments, it was recently announced by Drug Royalty that Drug Royalty and CMDF have invested $3.
CMDF has acquired and will acquire all its securities in Biocoll for investment purposes.
The portion of the acquisition and the financing involving CMDF was completed in escrow, pending the completion of certain steps to ensure that the shares of the Company are an eligible investment for CMDF under the Labour Sponsored Venture Capital Corporations Act, 1992 (Ontario).
Drug Royalty stated that it regards CMDF as a knowledgeable investor in biotechnology and pharmaceuticals and that CMDF's network will be helpful in expanding Drug Royalty's contact base.